<DOC>
	<DOCNO>NCT02005965</DOCNO>
	<brief_summary>The MERCURY Study demonstrate accuracy , feasibility reproducibility Magnetic Resonance Imaging ( MRI ) stage rectal cancer prospective , multidisciplinary , multi-centre study . However , difference patient outcome , dependent upon position tumour rectum height anal verge . Whilst outcome excellent patient underwent anterior resection , outcome , base upon margin involvement quality specimen , poor patient underwent abdomino-perineal excision low rectal cancer . It propose accurate MRI stag pre-operatively allow correct patient receive neo-adjuvant chemoradiotherapy ( CRT ) , also pre-warn surgeon resection margin appear threaten operation modify take account . The primary aim Low Rectal Cancer Study ( MERCURY II ) ass rate CRM positivity rate low rectal cancer ass difference global quality life two year post surgery patient accord plane surgery without sphincter preservation .</brief_summary>
	<brief_title>Low Rectal Cancer Study ( MERCURY II )</brief_title>
	<detailed_description>The aim study reduce positive margin rate 30 % around 15 % . The study international multicentre , prospective , observational study , whereby patient biopsy-proven low-rectal cancer ( low edge tumour &lt; 6cms anal verge MRI ) , recruit participate centre , give inform , write consent . Data radiology , surgical pathological aspect collect analyse centrally Royal Marsden Hospital . The patient 's medical record review five year post surgery , patient also follow quality life questionnaire . This project aim show low rectal cancer , improved local control survival achieve reduction involve CRM rate MRI-planned surgery selective pre-operative therapy . It also aim assess ability predict disease recurrence provide assessment disease-free survival overall survival .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<mesh_term>Neoplasms Site</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Rectal Diseases</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<mesh_term>Neoplasms Histologic Type</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Neoplasms , Cystic , Mucinous , Serous</mesh_term>
	<mesh_term>Adenocarcinoma , Mucinous</mesh_term>
	<criteria>Ability give informed , write consent . Adults age 18 male female . Recently diagnose biopsyproven , primary , low rectal cancer . No previous therapy rectal cancer . Current pregnancy , include ectopic pregnancy . Previous pelvic/rectal malignancy ( exclude carcinoma insitu ) . Previous pelvic radiotherapy . Previous pelvic floor surgery faecal incontinence prolapse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Rectal Cancer</keyword>
	<keyword>Low Rectal Cancer</keyword>
	<keyword>MERCURY</keyword>
	<keyword>Cancer</keyword>
	<keyword>CRM</keyword>
	<keyword>Circumferential Margin</keyword>
	<keyword>Quality Life</keyword>
	<keyword>MRI</keyword>
	<keyword>Radiology</keyword>
	<keyword>Abdominoperineal Excision</keyword>
	<keyword>Anterior Resection</keyword>
	<keyword>Surgery</keyword>
	<keyword>Pathology</keyword>
</DOC>